OMEGA THERAPEUTICS
Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.
OMEGA THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.omegatherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
212-600-1902
Total Funding:
239.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Tune Therapeutics
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
Current Advisors List
Board_member
Current Employees Featured
Yan Moore Chief Medical Officer @ Omega Therapeutics
Chief Medical Officer
2022-01-01
Thomas McCauley Chief Scientific Officer @ Omega Therapeutics
Chief Scientific Officer
2019-08-01
Mahesh Karande President and Chief Executive Officer @ Omega Therapeutics
President and Chief Executive Officer
2019-08-01
Omega Enterprises Founder @ Omega Therapeutics
Founder
2014-01-01
David Berry Founder @ Omega Therapeutics
Founder
2017-07-01
Noubar Afeyan Co-Founder @ Omega Therapeutics
Co-Founder
2018-01-01
Kevin McManus Chief Human Resources Officer @ Omega Therapeutics
Chief Human Resources Officer
2022-01-01
Roger Sawhney Chief Financial Officer @ Omega Therapeutics
Chief Financial Officer
2020-05-01
Founder
Stock Details
Investors List
LifeSci Venture Partners
LifeSci Venture Partners investment in Series C - Omega Therapeutics
Invus
Invus investment in Series C - Omega Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Omega Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series C - Omega Therapeutics
Point72
Point72 investment in Series C - Omega Therapeutics
Logos Capital
Logos Capital investment in Series C - Omega Therapeutics
Cowen and Company
Cowen and Company investment in Series C - Omega Therapeutics
BlackRock
BlackRock investment in Series C - Omega Therapeutics
Mirae Asset Capital
Mirae Asset Capital investment in Series C - Omega Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Omega Therapeutics
Key Employee Changes
Official Site Inspections
http://www.omegatherapeutics.com Semrush global rank: 4.65 M Semrush visits lastest month: 2.11 K
- Host name: 66-135-26-141.constant.com
- IP address: 66.135.26.141
- Location: Lehi United States
- Latitude: 40.3942
- Longitude: -111.8483
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84043
Omegatherapeutics.com lookup results from whois.networksolutions.com server:
- Domain created: 23rd-Nov-2016
- Domain updated: 24th-Sep-2021
- Domain expires: 23rd-Nov-2026 1 Year, 225 Days left
- Website age: 8 Years, 139 Days
- Registrar Domain ID: 2076270307_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS75.WORLDNIC.COM
- NS76.WORLDNIC.COM